Arctic Bioscience AS (OSL:ABS)

Arctic Bioscience AS Revenue

Arctic Bioscience AS had revenue of 25.04M NOK in the half year ending June 30, 2026, with 45.53% growth. This brings the company's total for the last twelve months to 48.96M, up 6.69% year-over-year. In the year 2025, Arctic Bioscience AS had annual revenue of 42.62M, down -4.01%. That makes Arctic Bioscience AS the 39,821st largest company in the world by revenue and 222nd in Norway.

• Revenue (ttm): 48.96M
• Revenue Growth: +6.69%
• P/S Ratio: 1.30
• Revenue / Employee: 2.58M
• Employees: 19
• Market Cap: 63.62M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• B2B 35.25M 87.9%
• B2C 4.85M 12.1%

By Geography

Chart

• Americas 13.32M 33.2%
• Europe 11.46M 28.6%
• APAC 8.02M 20.0%
• Norway 7.29M 18.2%

Fiscal year ended Dec 31, 2025 See the full Arctic Bioscience AS breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	42.62M	-1.78M	-4.01%
Dec 31, 2024	44.40M	10.65M	31.55%
Dec 31, 2023	33.76M	-713.30K	-2.07%
Dec 31, 2022	34.47M	12.95M	60.21%
Dec 31, 2021	21.52M	922.35K	4.48%
Dec 31, 2020	20.59M	-9.54M	-31.66%
Dec 31, 2019	30.13M	5.20M	20.85%
Dec 31, 2018	24.93M	6.49M	35.16%
Dec 31, 2017	18.45M	6.69M	56.86%
Dec 31, 2016	11.76M	8.21M	231.36%
Dec 31, 2013	3.55M	1.03M	40.88%
Dec 31, 2012	2.52M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 26, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Semi-annually

Last checked:

Oct 24, 2026

Data Sources Report a data error